CASC15 and esophageal squamous cell carcinoma: Our study demonstrates that combining MIR4435-2HG with another lncRNA, CASC15 (Cancer Susceptibility Candidate 15), enables the stratification of ESCC patients into distinct molecular subtypes with varying clinical outcomes.